Elena Putignano
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
MicroRNA-29 acutely regulates memory stability, expression of synaptic genes, and DNA methylation in the mouse adult hippocampus.
Journal: Cellular and molecular life sciences : CMLS
Published: November 25, 2024
Creatine transporter (SLC6A8) knockout mice exhibit reduced muscle performance, disrupted mitochondrial Ca2+ homeostasis, and severe muscle atrophy.
Journal: Cell death & disease
Published: August 14, 2024
Multi-site investigation of gut microbiota in CDKL5 deficiency disorder mouse models: Targeting dysbiosis to improve neurological outcomes.
Journal: Cell reports
Published: July 16, 2024
Connectomic and behavioural alterations in creatine transporter deficiency are partially normalized by gene therapy.
Journal: Brain : a journal of neurology
Published: May 21, 2024
Connectomic and behavioural alterations in creatine transporter deficiency are partially normalized by gene therapy.
Journal: Brain : a journal of neurology
Published: May 21, 2024
Cell-specific vulnerability to metabolic failure: the crucial role of parvalbumin expressing neurons in creatine transporter deficiency.
Journal: Acta neuropathologica communications
Published: December 20, 2022
Dodecyl creatine ester improves cognitive function and identifies key protein drivers including KIF1A and PLCB1 in a mouse model of creatine transporter deficiency.
Journal: Frontiers in molecular neuroscience
Published: December 07, 2022
Selective Disruption of Perineuronal Nets in Mice Lacking Crtl1 is Sufficient to Make Fear Memories Susceptible to Erasure.
Journal: Molecular neurobiology
Published: September 27, 2022
Behavioral impulsivity is associated with pupillary alterations and hyperactivity in CDKL5 mutant mice.
Journal: Human molecular genetics
Published: March 19, 2022
mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: February 04, 2022
Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency.
Journal: Scientific reports
Published: July 20, 2020
Last Updated: 09/26/2026